A Study of AP505 Injection in Patients With Advanced Malignant Solid Tumors
Clinical trial NCT06723964 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06723964
- Sponsor
- AP Biosciences Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-30
- Primary completion
- 2024-10-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.